Keloids: Current concepts in pathogenesis and treatment

Cosmetic Dermatology

Volumn 15, Issue 6, 2002, Pages 35-39

  Craft, Noah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

CONSULTATION; ESTHETIC SURGERY; HUMAN; KELOID; LASER SURGERY; PATHOGENESIS; REVIEW; SKIN SURGERY;

EID: 29244439598     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. English RS, and PD Shenefelt. Keloids and hypertrophic scars. Derm Surg. 1999;25:631-638.
2. Abrams BJ, Benedetto AV, Humeniuk HM. Exuberant keloid formation. JAOAC Int. 1993;93:863-865.
3. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. 1989;84:827-837.
4. Davies DM. Scars, hypertrophic scars, and keloids. Plast Reconstr Surg. 1985;290:1056-1058.
5. Cosman B, Crikelair GF, Ju MC, Gaulin JC, et al. The surgical treatment of keloids. Plast Reconstr Surg. 1961;27:335-345.
6. Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1000 patients with keloids in South India. Plast Reconstr Surg. 1974; 53:276-280.
7. Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids: a collective review. Plast Reconstr Surg. 1974;53:140-154.
8. Omo-Dare P. Genetic studies on keloids. J Natl Med Assoc. 1975;67:428-432.
9. Kurwa AR. Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol. 1979;4:251-254.
10. Goodfellow A, Emmerson RW, Calvert HT. Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol. 1980;5:369-370.
11. Selmantowitz VJ, Stiller MJ. Rubinstein-Taybi syndrome: cutaneous manifestations and colossal keloids. Arch Dermatol. 1981;117:504-506.
12. Siraganian PA, Rubinstein JH, Miller RW. Keloids and neoplasms in the Rubenstein-Taybi syndrome. Med Pediatr Oncol. 1989; 17:485-491.
13. Partington MW. Rubinstein-Taybi syndrome: a follow up study. Am J Med Genet Suppl. 1990;6:65-68.
14. Hendrix JD Jr, Greer KE. Rubinstein-Taybi syndrome with flamboyant keloids. Cutis. 1996;57:346-348.
15. Goeminne L. A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids, cryptorchidism, and renal dysplasia. Acta Genet Med Gemellol (Roma). 1968;17:439-467.
16. Zuffardi O, Fraccaro M. Gene mapping and serendipity: the locus for torticollis, keloids, cryptorchidism and renal dysplasia (31430, McKusick) is at Xq28, distal to the G6PD locus. Hum Genet. 1982;62:280-281.
17. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol. 2001;137:1429-1434.
18. Stegman SJ, Tromovitch TA, Glogan RG. Treatment of keloids. In: Stegman SJ, eds. Cosmetic Dermatologic Surgery, 2nd ed. Chicago: Year Book Medical; 1990:201-206.
19. Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63-67.
20. Murray JC. Scars and Keloids. Dermatol Clin. 1993;11:697-707.
21. Edwall D, Schalling M, Jennische E, Norstedt G. Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology. 1989;124:820-825.
22. Jennische E, Skottner A, Hansson HA. Satellite cells express the trophic factor IGF-1 in regenerating skeletal muscle. Acta Physiol Scand. 1986;126:609-614.
23. Hansson HA, Dahlin LB, Danielsen N, et al. Evidence indicating trophic importance in regenerating peripheral nerves. Acta Physiol Scand. 1986;126:609-614.
24. Yoshimoto H, Hiroshi I, Ohtsuru A, et al. Overexpression of insulin-like growth factor-1 (IGF-1) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathology. 1999;154:883-889.
25. Ghahary A, Shen YJ, Nedelec B, Scott PG, et al. Enhanced expression of mRNA for insulin-like growth factor-1 in post burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem. 1995;148(1):25-32.
26. Kim A, DiCarlo J, Cohen C, et al. Are keloids really "gli- loids"?: High-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol. 2001;45:707-711.
27. Green J, Leigh IM, Poulsom R, Quinn AG. Basal cell carcinoma development is associated with induction of the transcription factor Gli-1. Br J Dermatol. 1998;139:911-915.
28. Ghali L, Wong ST, Green J, Tidman N, et al. Gli-1 protein is expressed in basal cell carcinomas, outer root sheath keratin-ocytes and a subpopulation of mesenchymal cells in normal human skin. J Invest Dermatol. 1999;113:595-599.
29. Oro AE, Higgins KM, Hu Z, Bonifas JM, et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 1997; 276:817-821.
30. Nilsson M, Unden AB, Krause D, Malmqwist U, et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing gli-1. Proc Natl Acad Sci USA. 2000;97:3438-3443.
31. Fan H, Oro AE, Scott MP, Khavari PA. Induction of basal cell carcinoma features in transgenic human skin expressing sonic hedgehog. Nat Med. 1997;3:788-792.
32. Boyce DE, Ciampolini J, Ruge F, Murison MSC, et al. Inflammatory cell populations in keloid scars. Br J Plas Surg. 2001;54:511-516.
33. Riches DWH. Macrophage involvement in wound repair, remodelling and fibrosis. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press; 1996:95-131.
34. Friedman DW, Boyd CD, Mackenzie JW, Norton P, et al. Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res. 1993;55:214-222.
35. Regan MC, Kirk SJ, Hurson M, et al. Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery. 1993;113:173-177.
36. Cosman B, Crikelair GF, Ju MC, Gaulin JC, et al. The surgical treatment of keloidal scars. Plast Reconstr Surg. 1961;27:335-358.
37. Russell R, Horlock N, Gault D. Zimmer splintage: a simple effective treatment for keloids following ear-piercing. Br J Plas Surg. 2001;54:509-510.
38. Brent B. The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Surg. 1978;1:579-581.
39. Baur PS, Larson DL, Stacey TR, Barratt GJ, et al. Ultrastructural analysis of pressure treated human hypertrophic scars. J Trauma. 1976;16:958-967.
40. Berman B, Flores F. Comparison of a silicone gel-filled cushion and silicone gel sheating for the treatment of hypertrophic or keloid scars. Dermatol Surg. 1999;25:484-486.
41. Fulton JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg. 1995;21:947-951.
42. Swanson JW, LeBeau JW. The effect of implantation on the physical properties of silicone rubber. J Biomed Mater Res. 1974;8:357-367.
43. Quinn KG, Evans JH, Courtney JM, Gaylor JDS, et al. Non-pressure treatment of hypertrophic scars. Burns Incl Therm Inj. 1985;12:102-108.
44. Alster TS, West TB. Treatment of scars: A review. Ann Plast Surg. 1997;39:418-432.
45. Zouboulis CC, Blume U, Buttner P, Orfanos CE. Outcome of cryosurgery in keloids and hypertrophic scars. Arch Dermatol. 1993;129:1146-1151.
46. Rusciani L, Rosse G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19:529-534.
47. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22:126-130.
48. Lee Y, Minn K, Baek R, Hong JJ. A new surgical treatment of keloid: keloid core excision. Ann Plast Surg. 2001;46:135-140.
49. Borok TL, Bray M, Sinclair I, et al. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys. 1988;15:865-870.
50. Doornbos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys. 1990;18:833-839.
51. Sclafani AP, Gordon L, Chadha M, Romo T. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy. Dermatol Surg. 1996;22:569-574.
52. Ship AG, Weiss PR, Mincer FR, Wolkstein W. Sternal keloids: successful treatment employing surgery and adjuvant radiation. Ann Plast Surg. 1993;31:481-487.
53. Ragoowansi R, Cornes PGS, Glees JP, Powell BW, et al. Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg. 2001; 54:504-508.
54. Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol. 1999;72:1222-1224.
55. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46:563-597.
56. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed dye-laser. Lancet. 1995;345:1198-2000.
57. Kiil J. Keloids treated with topical injections of triamcinalone acetonide (Kenalog). Scand J Plast Reconstr Surg. 1977;11:169-172.
58. Wong TW, Chiu HC, Yip KM. Intralesional interferon alfa-2b has no effect in the treatment of keloids. Br J Dermatol. 1994;130:683-685.
59. Al-Khawajah MM. Failure of interferon alpha-2b in the treatment of mature keloids. Int J Dermatol. 1996;35:515-517.
60. Conejo-Mir JS, Corbi R. Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids. J Am Acad Dermatol. 1998;39:1039-1040.
61. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinalone, acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997;37:755-757.
62. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25:224-232.
63. Uppal RS, Khan U, Kakar S, et al. The effects of a singal dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg. 2001;108:1218-1224.
64. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27:23-27.
65. Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol. 1988;14:1275-1276.
66. Mikulec AA, Hanasono MM, Lum J, et al. Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg. 2001;3:111-114.
67. Chau D, Mancoll JS, Lee S, et al. Tamoxifen down regulates TGF-beta production in keloid fibroblasts. Ann Plast Surg. 1998;40:490-493.
68. Hu D, Hughes MA, Cherry GW. Topical tamoxifen - a potential therapeutic regime in treating excessive dermal scarring? Br J Plast Surg. 1998;51:462-469.